Investment Column : Alliance Pharma | 09-Sep-2010 | The Independent |
Investment Column:Alliance Pharma | 19-Mar-2009 | The Independent |
Market report: Thursday latest | 13-Sep-2007 | Daily Mail |
Gloomy summer casts shadow over Next | 10-Sep-2007 | The Independent |
Currency | UK Pounds |
Share Price | 38.80p |
Change Today | -0.30p |
% Change | -0.77 % |
52 Week High | 62.00 |
52 Week Low | 29.35 |
Volume | 1,001,727 |
Shares Issued | 540.40m |
Market Cap | £209.68m |
RiskGrade | 119 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 0 |
Neutral | 3 |
Sell | 0 |
Strong Sell | 0 |
Total | 7 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 22-Jun-23 | 22-Dec-22 |
Paid | 18-Jul-23 | 19-Jan-23 |
Amount | 1.18p | 0.59p |
Time | Volume / Share Price |
16:35 | 3,036 @ 38.80p |
16:35 | 94 @ 38.80p |
16:35 | 54 @ 38.80p |
16:35 | 872 @ 38.80p |
16:35 | 495 @ 38.80p |
CEO | Peter Butterfield |
CFO | Andrew Franklin |
Chair | Camillo Pane |
You are here: research